A latest investigation into its molecular mechanism found that the hypoxia-selective BE-43547A2 exerts its anti-tumor effects through a sophisticated regulation of the HIF1α-eEF1A1-FoxO1-JAK/STAT3 signaling axis [87]. The gene discussed is FOXO1; the disease is neoplasm.